CELESTICA INC (CLS) 12.37 -0.07 (-0.56%)
12.37 -0.07 (-0.56%)
CA15101Q1081 - Common Stock - After market: 12.37 0 (0%)
Buy % Consensus
Analysts have set a mean price target of 11.35. This target is -8.29% below the current price.
CLS was analyzed by 8 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CLS.
In the previous month the buy percentage consensus was at a similar level.
CLS was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-02-23 | RBC Capital | Reiterate | Sector Perform |
| 2023-01-27 | BMO Capital | Maintains | Outperform |
| 2023-01-27 | Citigroup | Maintains | Neutral |
| 2022-10-26 | RBC Capital | Maintains | Sector Perform |
| 2022-10-26 | Citigroup | Maintains | Neutral |
| 2022-08-18 | Argus Research | Upgrade | Hold -> Buy |
| 2022-07-27 | BMO Capital | Upgrade | Market Perform -> Outperform |
| 2022-07-27 | Citigroup | Upgrade | Sell -> Neutral |
| 2021-09-23 | RBC Capital | Maintains | Sector Perform |
| 2021-07-29 | TD Securities | Upgrade | Hold |
| 2021-07-28 | RBC Capital | Upgrade | Sector Perform |
| 2021-07-28 | TD Securities | Upgrade | Hold |
| 2021-06-04 | RBC Capital | Maintains | Sector Perform |
| 2021-04-30 | RBC Capital | Initiate | Sector Perform |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA